[
  {
    "ts": "2025-11-12T02:55:10+00:00",
    "headline": "TD Cowen Maintains a Hold on Pfizer Inc. (PFE) With a $30 PT",
    "summary": "Pfizer Inc. (NYSE:PFE) is one of the best undervalued stocks to buy under $50. Pfizer Inc. (NYSE:PFE) received a rating update from TD Cowen analyst Steve Scala on November 4, who maintained a Hold rating on the stock and set a $30 price target. Pfizer Inc. (NYSE:PFE) reported its fiscal Q3 2025 results the same […]",
    "url": "https://finance.yahoo.com/news/td-cowen-maintains-hold-pfizer-025510815.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "673f736c-e302-3e51-9bcf-8e3ac09fa280",
      "content": {
        "id": "673f736c-e302-3e51-9bcf-8e3ac09fa280",
        "contentType": "STORY",
        "title": "TD Cowen Maintains a Hold on Pfizer Inc. (PFE) With a $30 PT",
        "description": "",
        "summary": "Pfizer Inc. (NYSE:PFE) is one of the best undervalued stocks to buy under $50. Pfizer Inc. (NYSE:PFE) received a rating update from TD Cowen analyst Steve Scala on November 4, who maintained a Hold rating on the stock and set a $30 price target. Pfizer Inc. (NYSE:PFE) reported its fiscal Q3 2025 results the same […]",
        "pubDate": "2025-11-12T02:55:10Z",
        "displayTime": "2025-11-12T02:55:10Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/aef4b35e5ea946bf7f4ed347e5c4f487",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Pfizer’s (PFE) Pipeline and Dividend Yield Make it a Compelling Income Stock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UKiv8LHLxutAA7dDIzr_pw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/aef4b35e5ea946bf7f4ed347e5c4f487.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1v0rnd.QZj0de1gLzaNuAg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/aef4b35e5ea946bf7f4ed347e5c4f487.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/td-cowen-maintains-hold-pfizer-025510815.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/td-cowen-maintains-hold-pfizer-025510815.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T04:37:16+00:00",
    "headline": "1 Large-Cap Stock for Long-Term Investors and 2 We Turn Down",
    "summary": "Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.",
    "url": "https://finance.yahoo.com/news/1-large-cap-stock-long-043716148.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "120328b4-dafd-3d9d-b122-89625089d3bc",
      "content": {
        "id": "120328b4-dafd-3d9d-b122-89625089d3bc",
        "contentType": "STORY",
        "title": "1 Large-Cap Stock for Long-Term Investors and 2 We Turn Down",
        "description": "",
        "summary": "Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.",
        "pubDate": "2025-11-12T04:37:16Z",
        "displayTime": "2025-11-12T04:37:16Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/3a2a1c7d186ab334fda549bbd94ffd9e",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "STX Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vFYagrS.OteqKOyVgv_QKw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/3a2a1c7d186ab334fda549bbd94ffd9e.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/t96dHXEk2KolmI5cqyKw.w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/3a2a1c7d186ab334fda549bbd94ffd9e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/1-large-cap-stock-long-043716148.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/1-large-cap-stock-long-043716148.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MDLZ"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "STX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T09:35:00+00:00",
    "headline": "Why Metsera's Share Price Is Plummeting This Week",
    "summary": "The biotech start-up's stock had been rising rapidly in 2025.",
    "url": "https://www.fool.com/investing/2025/11/12/why-metseras-share-price-is-plummeting-this-week/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "5710a1e8-bddb-37a1-a655-62e98ada54e4",
      "content": {
        "id": "5710a1e8-bddb-37a1-a655-62e98ada54e4",
        "contentType": "STORY",
        "title": "Why Metsera's Share Price Is Plummeting This Week",
        "description": "",
        "summary": "The biotech start-up's stock had been rising rapidly in 2025.",
        "pubDate": "2025-11-12T09:35:00Z",
        "displayTime": "2025-11-12T09:35:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/7a8a5738e5600072dcb18cc3b537caeb",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "A doctor prescribing medications.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VJiC6r4B6qi2JvpoxD5PqQ--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/7a8a5738e5600072dcb18cc3b537caeb.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VTjbvif97Z4PRfas6g323g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/7a8a5738e5600072dcb18cc3b537caeb.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/12/why-metseras-share-price-is-plummeting-this-week/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-metseras-share-price-plummeting-093500112.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T15:31:16+00:00",
    "headline": "Pfizer: Could AI unlock new value for drug makers?",
    "summary": "Pfizer (PFE) managed to outbid competitor Novo Nordisk (NVO) to acquire Metsera (MTSR) in a deal valued at up to $10 billion. Pfizer stock is down by nearly 3% from this time a year ago. Robinhood (HOOD) Chief Investment Officer Stephanie Guild and Yahoo Finance senior reporters Brooke DiPalma and Ines Ferré discuss Pfizer's position in the healthcare space (XLV) and whether artificial intelligence could unlock new growth prospects for the pharmaceutical industry. Tune in on Thursday, November 13, for Yahoo Finance's interview with Pfizer CEO Albert Bourla at Yahoo Finance Invest. To watch more expert insights and analysis on the latest market action, check out more&nbsp;Opening Bid.",
    "url": "https://finance.yahoo.com/video/pfizer-could-ai-unlock-value-153116404.html",
    "source": "Yahoo Finance Video",
    "provider": "yfinance",
    "raw": {
      "id": "b2091c41-c052-3fde-b1db-48e35babed91",
      "content": {
        "id": "b2091c41-c052-3fde-b1db-48e35babed91",
        "contentType": "VIDEO",
        "title": "Pfizer: Could AI unlock new value for drug makers?",
        "description": "<p>Pfizer (<a data-i13n=\"cpos:1;pos:1\" href=\"https://finance.yahoo.com/quote/PFE\">PFE</a>) <a data-i13n=\"cpos:2;pos:1\" href=\"https://finance.yahoo.com/video/why-metsera-better-hands-pfizer-193000280.html\">managed to outbid competitor</a> Novo Nordisk (<a data-i13n=\"cpos:3;pos:1\" href=\"https://finance.yahoo.com/quote/NVO\">NVO</a>) to acquire Metsera (<a data-i13n=\"cpos:4;pos:1\" href=\"https://finance.yahoo.com/quote/MTSR\">MTSR</a>) in a deal valued at up to $10 billion. Pfizer stock is down by nearly 3% from this time a year ago.</p>\n<p>Robinhood (<a data-i13n=\"cpos:5;pos:1\" href=\"https://finance.yahoo.com/quote/HOOD\">HOOD</a>) Chief Investment Officer Stephanie Guild and Yahoo Finance senior reporters <a data-i13n=\"cpos:6;pos:1\" href=\"https://www.yahoo.com/author/brooke-dipalma/\">Brooke DiPalma</a> and <a data-i13n=\"cpos:7;pos:1\" href=\"https://finance.yahoo.com/author/ines-ferre/\">Ines Ferré</a> discuss Pfizer's position in the healthcare space (<a data-i13n=\"cpos:8;pos:1\" href=\"https://finance.yahoo.com/quote/XLV\">XLV</a>) and whether artificial intelligence could unlock new growth prospects for the pharmaceutical industry.</p>\n<p>Tune in on Thursday, November 13, for Yahoo Finance's interview with Pfizer CEO Albert Bourla at <a data-i13n=\"cpos:9;pos:1\" href=\"https://finance.yahoo.com/topic/yf-invest/\">Yahoo Finance Invest</a>.</p>\n<p>To watch more expert insights and analysis on the latest market action, check out more <a data-i13n=\"cpos:10;pos:1\" href=\"https://finance.yahoo.com/videos/series/opening-bid/\">Opening Bid</a>.</p>",
        "summary": "Pfizer (PFE) managed to outbid competitor Novo Nordisk (NVO) to acquire Metsera (MTSR) in a deal valued at up to $10 billion. Pfizer stock is down by nearly 3% from this time a year ago. Robinhood (HOOD) Chief Investment Officer Stephanie Guild and Yahoo Finance senior reporters Brooke DiPalma and Ines Ferré discuss Pfizer's position in the healthcare space (XLV) and whether artificial intelligence could unlock new growth prospects for the pharmaceutical industry. Tune in on Thursday, November 13, for Yahoo Finance's interview with Pfizer CEO Albert Bourla at Yahoo Finance Invest. To watch more expert insights and analysis on the latest market action, check out more&nbsp;Opening Bid.",
        "pubDate": "2025-11-12T15:31:16Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-11/94f8f7a0-bfdc-11f0-add6-d18375663e37",
          "originalWidth": 6000,
          "originalHeight": 3378,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AyAIJdilBYvpIKUcqTV7UQ--~B/aD0zMzc4O3c9NjAwMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-11/94f8f7a0-bfdc-11f0-add6-d18375663e37.cf.webp",
              "width": 6000,
              "height": 3378,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Q.5_hfsnd7iYpmSnZ3_G1A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-11/94f8f7a0-bfdc-11f0-add6-d18375663e37.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance Video",
          "url": "https://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/pfizer-could-ai-unlock-value-153116404.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/pfizer-could-ai-unlock-value-153116404.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "XLV"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "HOOD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T15:28:00+00:00",
    "headline": "USA Dietary Supplements Market Forecast and Company Analysis Report 2025-2033 Featuring Amway, Abbott, Glanbia, Bayer, Pfizer, Suntory, Herbalife, Haleon, Otsuka, Bountiful",
    "summary": "The United States Dietary Supplements Market, projected to grow from US$ 54.24 billion in 2024 to US$ 103.56 billion by 2033, is driven by rising health awareness and demand for preventive healthcare, alongside growing fitness trends and an aging population. Busy lifestyles, online retail expansion, and innovation in supplement formulations further stimulate market growth. Popular for their role in enhancing immunity, fitness, and general health, dietary supplements include vitamins, minerals, a",
    "url": "https://finance.yahoo.com/news/usa-dietary-supplements-market-forecast-152800414.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "373966e3-e364-3c2c-bf7c-0b0fcbc1ac6d",
      "content": {
        "id": "373966e3-e364-3c2c-bf7c-0b0fcbc1ac6d",
        "contentType": "STORY",
        "title": "USA Dietary Supplements Market Forecast and Company Analysis Report 2025-2033 Featuring Amway, Abbott, Glanbia, Bayer, Pfizer, Suntory, Herbalife, Haleon, Otsuka, Bountiful",
        "description": "",
        "summary": "The United States Dietary Supplements Market, projected to grow from US$ 54.24 billion in 2024 to US$ 103.56 billion by 2033, is driven by rising health awareness and demand for preventive healthcare, alongside growing fitness trends and an aging population. Busy lifestyles, online retail expansion, and innovation in supplement formulations further stimulate market growth. Popular for their role in enhancing immunity, fitness, and general health, dietary supplements include vitamins, minerals, a",
        "pubDate": "2025-11-12T15:28:00Z",
        "displayTime": "2025-11-12T15:28:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/d897fb1843620977d9950230b105d59e",
          "originalWidth": 600,
          "originalHeight": 400,
          "caption": "U.S. Dietary Supplements Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/M8fHD3jhjZwE6S0npUHeLw--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/d897fb1843620977d9950230b105d59e.cf.webp",
              "width": 600,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/M74XtgFhaIG36hhPuiLDlw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/d897fb1843620977d9950230b105d59e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/usa-dietary-supplements-market-forecast-152800414.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/usa-dietary-supplements-market-forecast-152800414.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GL9.IR"
            },
            {
              "symbol": "BAYN.DE"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "HLF"
            },
            {
              "symbol": "HLN.L"
            },
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T15:15:00+00:00",
    "headline": "2 Strong Healthcare Stock Picks for Value Investors",
    "summary": "Value-driven plays abound in the top healthcare stocks.",
    "url": "https://www.fool.com/investing/2025/11/12/2-strong-healthcare-stock-picks-for-value-investor/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "9f88ab90-52c1-39dc-bfa9-c5f0f17c4e30",
      "content": {
        "id": "9f88ab90-52c1-39dc-bfa9-c5f0f17c4e30",
        "contentType": "STORY",
        "title": "2 Strong Healthcare Stock Picks for Value Investors",
        "description": "",
        "summary": "Value-driven plays abound in the top healthcare stocks.",
        "pubDate": "2025-11-12T15:15:00Z",
        "displayTime": "2025-11-12T15:15:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/4a6262307e70e15da6a6040be6b1612f",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": " investor taking notes at computer",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pnER1kmr4jb2HFXfgz2.gw--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/4a6262307e70e15da6a6040be6b1612f.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SnbVnY8NtM35JDmq8FY1EQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/4a6262307e70e15da6a6040be6b1612f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/12/2-strong-healthcare-stock-picks-for-value-investor/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-strong-healthcare-stock-picks-151500650.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T15:00:00+00:00",
    "headline": "Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference",
    "summary": "NEW YORK, November 12, 2025--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with Dave Denton, Chief Financial Officer, Executive Vice President, at the Jefferies London Healthcare Conference on Wednesday, November 19, 2025 at 9:00 a.m. GMT.",
    "url": "https://finance.yahoo.com/news/pfizer-invites-public-view-listen-150000751.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "a2922877-cdce-3e95-b2c3-fdabc2406d28",
      "content": {
        "id": "a2922877-cdce-3e95-b2c3-fdabc2406d28",
        "contentType": "STORY",
        "title": "Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference",
        "description": "",
        "summary": "NEW YORK, November 12, 2025--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with Dave Denton, Chief Financial Officer, Executive Vice President, at the Jefferies London Healthcare Conference on Wednesday, November 19, 2025 at 9:00 a.m. GMT.",
        "pubDate": "2025-11-12T15:00:00Z",
        "displayTime": "2025-11-12T15:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/063266e4d8a0b574fd4f1e26561b19f2",
          "originalWidth": 480,
          "originalHeight": 212,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w8J6ECLE1N2JlaZDS1bKoQ--~B/aD0yMTI7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/063266e4d8a0b574fd4f1e26561b19f2.cf.webp",
              "width": 480,
              "height": 212,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/71DoY0u_4SSpC8Nv8SrWCQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/063266e4d8a0b574fd4f1e26561b19f2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-invites-public-view-listen-150000751.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-invites-public-view-listen-150000751.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T17:10:06+00:00",
    "headline": "Jim Cramer Finds Pfizer (PFE)’s Stock Level “Unfathomable”",
    "summary": "We recently published 12 Latest Stocks on Jim Cramer’s Radar . Pfizer Inc. (NYSE:PFE) is one of the stocks Jim Cramer recently discussed. Jim Cramer has discussed pharma giant Pfizer Inc. (NYSE:PFE) several times recently. He has repeatedly commented on how the stock trades more like a bond rather than an equity due to its […]",
    "url": "https://finance.yahoo.com/news/jim-cramer-finds-pfizer-pfe-171006276.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "ca9eb5f0-4e85-38c9-be5e-365cb1918f45",
      "content": {
        "id": "ca9eb5f0-4e85-38c9-be5e-365cb1918f45",
        "contentType": "STORY",
        "title": "Jim Cramer Finds Pfizer (PFE)’s Stock Level “Unfathomable”",
        "description": "",
        "summary": "We recently published 12 Latest Stocks on Jim Cramer’s Radar . Pfizer Inc. (NYSE:PFE) is one of the stocks Jim Cramer recently discussed. Jim Cramer has discussed pharma giant Pfizer Inc. (NYSE:PFE) several times recently. He has repeatedly commented on how the stock trades more like a bond rather than an equity due to its […]",
        "pubDate": "2025-11-12T17:10:06Z",
        "displayTime": "2025-11-12T17:10:06Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/ff8020a547cc353e36a06eaa2c1811e3",
          "originalWidth": 856,
          "originalHeight": 1280,
          "caption": "Jim Cramer Finds Pfizer (PFE)'s Stock Level \"Unfathomable\"",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/u668xcIVjh91PPDvxEipUQ--~B/aD0xMjgwO3c9ODU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/ff8020a547cc353e36a06eaa2c1811e3.cf.webp",
              "width": 856,
              "height": 1280,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xja.geSyAE57pHVIh2oUCg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/ff8020a547cc353e36a06eaa2c1811e3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-finds-pfizer-pfe-171006276.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-finds-pfizer-pfe-171006276.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T17:09:56+00:00",
    "headline": "Jim Cramer Discusses CoreWeave (CRWV)’s Debt Levels",
    "summary": "We recently published 12 Latest Stocks on Jim Cramer’s Radar . CoreWeave, Inc. (NASDAQ:CRWV) is one of the stocks Jim Cramer recently discussed. CoreWeave, Inc. (NASDAQ:CRWV) is a computing infrastructure firm that hosts GPUs and other hardware for AI software companies. Its inventory of NVIDIA GPUs has made the firm a key player in the […]",
    "url": "https://finance.yahoo.com/news/jim-cramer-discusses-coreweave-crwv-170956888.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "00c8737e-716e-3bae-924b-3d936373d97f",
      "content": {
        "id": "00c8737e-716e-3bae-924b-3d936373d97f",
        "contentType": "STORY",
        "title": "Jim Cramer Discusses CoreWeave (CRWV)’s Debt Levels",
        "description": "",
        "summary": "We recently published 12 Latest Stocks on Jim Cramer’s Radar . CoreWeave, Inc. (NASDAQ:CRWV) is one of the stocks Jim Cramer recently discussed. CoreWeave, Inc. (NASDAQ:CRWV) is a computing infrastructure firm that hosts GPUs and other hardware for AI software companies. Its inventory of NVIDIA GPUs has made the firm a key player in the […]",
        "pubDate": "2025-11-12T17:09:56Z",
        "displayTime": "2025-11-12T17:09:56Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/8d483b146d91b4119ec83ba6c9dff08c",
          "originalWidth": 1920,
          "originalHeight": 1280,
          "caption": "Jim Cramer Discusses CoreWeave (CRWV)'s Debt Levels",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uI5oWI0D6Yd6L4kX7coMcw--~B/aD0xMjgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/8d483b146d91b4119ec83ba6c9dff08c.cf.webp",
              "width": 1920,
              "height": 1280,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xSvlY0I9D09f_zoPKY3Ytw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/8d483b146d91b4119ec83ba6c9dff08c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-discusses-coreweave-crwv-170956888.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-discusses-coreweave-crwv-170956888.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRWV"
            },
            {
              "symbol": "BTC-USD"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]